The CL subtype was significantly more likely to express the mammary stem cell/breast tumor initiating cell marker ALDH1 (p = 0.01) than non-CL tumors and there was a trend for association between CL tumors and the CD44hi/CD24low/- phenotype (p = 0.09). This evidence concerns the gene ALDH1A1 and breast neoplasm.